Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1099)
BeOne Medicines Ltd. (ONC)
Yi Qingqing — Director
Shares
235
Price
$279.13
Total Value
$65.60K
Shares Held After
0
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
3,931
Price
$70.75
Total Value
$278.10K
Shares Held After
8,977
% of Holdings
30.5%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
21,069
Price
$70.11
Total Value
$1.48M
Shares Held After
12,908
% of Holdings
62.0%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
40,000
Price
$70.00
Total Value
$2.80M
Shares Held After
15,257
% of Holdings
72.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,889
Price
$29.66
Total Value
$85.70K
Shares Held After
793
% of Holdings
78.5%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
1,346
Price
$28.79
Total Value
$38.76K
Shares Held After
3,682
% of Holdings
26.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
1,700
Price
$27.78
Total Value
$47.23K
Shares Held After
5,028
% of Holdings
25.3%
EXELIXIS, INC. (EXEL)
WYSZOMIERSKI JACK L — Director
Shares
3,925
Price
$50.55
Total Value
$198.41K
Shares Held After
284,384
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
Eckhardt Sue Gail — Director
Shares
9,812
Price
$50.14
Total Value
$491.97K
Shares Held After
16,079
% of Holdings
37.9%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
80,459
Price
$0.47
Total Value
$37.82K
Shares Held After
542,120
% of Holdings
12.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
17
Price
$302.65
Total Value
$5.15K
Shares Held After
1,582
% of Holdings
1.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
495
Price
$300.72
Total Value
$148.86K
Shares Held After
1,599
% of Holdings
23.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
1,222
Price
$299.87
Total Value
$366.44K
Shares Held After
2,094
% of Holdings
36.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
1,175
Price
$298.91
Total Value
$351.22K
Shares Held After
3,316
% of Holdings
26.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
921
Price
$297.71
Total Value
$274.19K
Shares Held After
4,491
% of Holdings
17.0%
IONIS PHARMACEUTICALS INC (IONS)
BERTHELSEN SPENCER R — Director
Shares
8,000
Price
$75.67
Total Value
$605.36K
Shares Held After
156,013
% of Holdings
4.9%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$235.12
Total Value
$1.41M
Shares Held After
372,682
% of Holdings
1.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,795
Price
$30.58
Total Value
$54.89K
Shares Held After
34,826
% of Holdings
4.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
1,600
Price
$26.36
Total Value
$42.17K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
13,253
Price
$25.57
Total Value
$338.94K
Shares Held After
1,600
% of Holdings
89.2%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
301
Price
$50.26
Total Value
$15.13K
Shares Held After
158,494
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,949
Price
$49.40
Total Value
$96.29K
Shares Held After
158,795
% of Holdings
1.2%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
553
Price
$26.24
Total Value
$14.51K
Shares Held After
27,970
% of Holdings
1.9%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
6,090
Price
$26.20
Total Value
$159.54K
Shares Held After
344,897
% of Holdings
1.7%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
276
Price
$60.87
Total Value
$16.80K
Shares Held After
146,743
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
200
Price
$103.84
Total Value
$20.77K
Shares Held After
85,533
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
279
Price
$101.79
Total Value
$28.40K
Shares Held After
85,733
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,588
Price
$100.65
Total Value
$260.48K
Shares Held After
86,012
% of Holdings
2.9%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,133
Price
$99.86
Total Value
$312.86K
Shares Held After
88,600
% of Holdings
3.4%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
1,200
Price
$98.57
Total Value
$118.28K
Shares Held After
91,733
% of Holdings
1.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
900
Price
$97.68
Total Value
$87.91K
Shares Held After
92,933
% of Holdings
1.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,170
Price
$95.99
Total Value
$208.30K
Shares Held After
93,833
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
960
Price
$94.87
Total Value
$91.08K
Shares Held After
96,003
% of Holdings
1.0%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
15,000
Price
$60.22
Total Value
$903.30K
Shares Held After
15,000
% of Holdings
50.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
99
Price
$15.34
Total Value
$1.52K
Shares Held After
12,838,101
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
343,521
Price
$15.28
Total Value
$5.25M
Shares Held After
12,838,002
% of Holdings
2.7%
GENELUX Corp (GNLX)
Thomas John — Director
Shares
10,000
Price
$2.98
Total Value
$29.80K
Shares Held After
472,784
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
3,977
Price
$100.00
Total Value
$397.70K
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
883
Price
$99.66
Total Value
$88.00K
Shares Held After
194,309
% of Holdings
0.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,021
Price
$98.20
Total Value
$100.26K
Shares Held After
195,192
% of Holdings
0.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,973
Price
$97.56
Total Value
$192.49K
Shares Held After
196,213
% of Holdings
1.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,926
Price
$96.15
Total Value
$665.93K
Shares Held After
198,186
% of Holdings
3.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
16,595
Price
$95.34
Total Value
$1.58M
Shares Held After
205,112
% of Holdings
7.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,602
Price
$94.64
Total Value
$246.25K
Shares Held After
221,707
% of Holdings
1.2%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
9,747
Price
$9.62
Total Value
$93.77K
Shares Held After
130,079
% of Holdings
7.0%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
12,837
Price
$69.74
Total Value
$895.25K
Shares Held After
2,565,489
% of Holdings
0.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
468
Price
$19.73
Total Value
$9.23K
Shares Held After
594,538
% of Holdings
0.1%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
4,998
Price
$19.41
Total Value
$97.02K
Shares Held After
595,006
% of Holdings
0.8%
NovaBridge Biosciences (NBP)
Xu Cong Claire — SVP, Clinical Development
Shares
3,494
Price
$3.94
Total Value
$13.77K
Shares Held After
290,154
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
4,159
Price
$91.37
Total Value
$380.01K
Shares Held After
4,000
% of Holdings
51.0%
Showing 801–850 of 1099 transactions (page 17 of 22)